There is an increased inflammatory response in patients living with T2D, as demonstrated by elevated levels of inflammatory markers such as interleukin 6 (IL-6), tumour necrosis factor-alpha (TNF-α), and C-reactive protein (CRP) present in the blood [7]. The gene discussed is CRP; the disease is type 2 diabetes mellitus.